Insulet Reports Full Year 2021 Revenue Increase of 21% and Fourth Quarter 2021 Revenue Increase of 25% Year-Over-Year
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Insulet Corporation (PODD) PT Lowered to $310 at BTIG
February 24, 2022 12:59 PM ESTBTIG analyst Marie Thibault lowered the price target on Insulet Corporation (NASDAQ: PODD) to $310.00 (from $320.00) while maintaining a Buy rating.
The analyst commented, "Insulet reported Q4 revenue of $307.7M (+25% y/y rep, +25.7% y/y cc), beating consensus estimates of $299.3M and our $303.2M forecast. U.S. Omnipod revenue was relatively in line with our expectations but OUS headwinds, including ongoing pressures from competitive AID systems and an estimated $5M... More
Insulet (PODD) Tops Q4 EPS by 10c
February 23, 2022 4:07 PM ESTInsulet (NASDAQ: PODD) reported Q4 EPS of $0.42, $0.10 better than the analyst estimate of $0.32. Revenue for the quarter came in at $307.7 million versus the consensus estimate of $301.06 million.
GUIDANCE:
For the year ending December 31, 2022, the Company expects revenue growth in... More
